August 2018

An understanding of the limitations in their functionality and strategies for more appropriate applications are necessary for clinicians.

Medication advancements offer more options and formulations for treating pediatric patients living with HIV.

Aerosolized antibiotics are a reasonable adjunctive option to treat multidrug-resistant gram-negative pneumonia due to excellent pulmonary concentrations and few adverse effects.

New geographical spread of the disease may warrant increased vigilance among labs and clinicians.

Contagion® editor-in-chief, Jason C. Gallagher, PharmD, FCCP, FIDSA, BCPS, affirms that the health care industry needs to hit the reset button on how antibiotics are developed.

Moving away from the standard course of IV antibiotics.

In addition to other updates, new breakpoints have been added for cefiderocol and meropenem-vaborbactam.

Gram-positive multidrug-resistant infections may be managed effectively with a single dose of long-acting lipo­glycopeptide antibiotics in the outpatient setting; however, careful patient selection is important for maximizing the cost-benefit of these relatively expensive drugs.

Targeting stewardship interventions to the morning hours may have a greater impact than afternoons and nights.

Fecal microbiota transplantation (FMT) is a widely accepted, safe, and effective treatment for recurrent Clostridium diffi­cile infection (rCDI), but does the cure endure?

A team of physicians yields surprising findings in an elderly patient in shock with seizures.